BioXcel Therapeutics, Inc.

Bioxcel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical development company. The Company utilizes big data, machine learning, and artificial intelligence to identify the next wave of medicines across neuroscience, immuno-oncology, and related diseases. BioXcel Therapeutics serves customers in the State of Connecticut.

Bank Name BioXcel Therapeutics, Inc.
Stock Exchange NASDAQ
Symbol BTAI
Sector Healthcare
Industry Major Pharmaceuticals
Country United States
World Region America
Chairman
CEO Dr. Vimal D. Mehta Ph.D.
Employees 4
Website www.bioxceltherapeutics.com
Registered Year 2017

UpdateContent
UpdateContent
UpdateContent